Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 298

1.

Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.

Nolte H, Casale TB, Lockey RF, Fogh BS, Kaur A, Lu S, Nelson HS.

J Allergy Clin Immunol Pract. 2016 Nov 9. pii: S2213-2198(16)30402-0. doi: 10.1016/j.jaip.2016.08.017. [Epub ahead of print]

PMID:
27838323
2.

Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.

Nelson HS.

Expert Rev Clin Pharmacol. 2016 Oct 6:1-9. [Epub ahead of print]

PMID:
27687128
3.

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.

Durham SR, Creticos PS, Nelson HS, Li Z, Kaur A, Meltzer EO, Nolte H.

J Allergy Clin Immunol. 2016 Oct;138(4):1081-1088.e4. doi: 10.1016/j.jaci.2016.04.061.

PMID:
27527264
4.

Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.

Nolte H, Bernstein DI, Nelson HS, Kleine-Tebbe J, Sussman GL, Seitzberg D, Rehm D, Kaur A, Li Z, Lu S.

J Allergy Clin Immunol. 2016 Aug 10. pii: S0091-6749(16)30783-7. doi: 10.1016/j.jaci.2016.06.044. [Epub ahead of print]

PMID:
27521719
5.

Allergen immunotherapy now and in the future.

Nelson HS.

Allergy Asthma Proc. 2016 Jul;37(4):268-72. doi: 10.2500/aap.2016.37.3966.

PMID:
27401313
6.

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML, Wise RA, Szefler SJ, Sharma S, Kho AT, Cho MH, Croteau-Chonka DC, Castaldi PJ, Jain G, Sanyal A, Zhan Y, Lajoie BR, Dekker J, Stamatoyannopoulos J, Covar RA, Zeiger RS, Adkinson NF, Williams PV, Kelly HW, Grasemann H, Vonk JM, Koppelman GH, Postma DS, Raby BA, Houston I, Lu Q, Fuhlbrigge AL, Tantisira KG, Silverman EK, Tonascia J, Weiss ST, Strunk RC; CAMP Research Group..

N Engl J Med. 2016 May 12;374(19):1842-52. doi: 10.1056/NEJMoa1513737.

7.

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

Dahl R, Roberts G, de Blic J, Canonica GW, Kleine-Tebbe J, Nolte H, Lawton S, Nelson HS.

Allergy Asthma Proc. 2016 Mar-Apr;37(2):92-104. doi: 10.2500/aap.2016.37.3937.

PMID:
26802643
8.

Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.

Maloney J, Berman G, Gagnon R, Bernstein DI, Nelson HS, Kleine-Tebbe J, Kaur A, Li Q, Nolte H.

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):301-9.e2. doi: 10.1016/j.jaip.2015.11.004.

9.

Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.

Nelson HS, Makatsori M, Calderon MA.

Immunol Allergy Clin North Am. 2016 Feb;36(1):13-24. doi: 10.1016/j.iac.2015.08.005. Review.

PMID:
26617224
10.

Short ragweeds is highly cross-reactive with other ragweeds.

Christensen LH, Ipsen H, Nolte H, Maloney J, Nelson HS, Weber R, Lund K.

Ann Allergy Asthma Immunol. 2015 Dec;115(6):490-495.e1. doi: 10.1016/j.anai.2015.09.016.

PMID:
26507708
11.

Airway Obstruction Worsens in Young Adults with Asthma Who Become Obese.

Strunk RC, Colvin R, Bacharier LB, Fuhlbrigge A, Forno E, Arbelaez AM, Tantisira KG; Childhood Asthma Management Program Research Group..

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):765-71.e2. doi: 10.1016/j.jaip.2015.05.009.

12.

Allergen immunotherapy: what's new, what's next?

Nelson HS.

Expert Rev Clin Immunol. 2015;11(9):959-61. doi: 10.1586/1744666X.2015.1062726.

PMID:
26134252
13.

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.

Beasley RW, Donohue JF, Mehta R, Nelson HS, Clay M, Moton A, Kim HJ, Hederer BM.

BMJ Open. 2015 Feb 3;5(2):e006131. doi: 10.1136/bmjopen-2014-006131.

14.

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.

Nolte H, Maloney J, Nelson HS, Bernstein DI, Lu S, Li Z, Kaur A, Zieglmayer P, Zieglmayer R, Lemell P, Horak F.

J Allergy Clin Immunol. 2015 Jun;135(6):1494-501.e6. doi: 10.1016/j.jaci.2014.12.1911.

PMID:
25636947
15.

Recommendations for the pharmacologic management of allergic rhinitis.

Hoyte FC, Meltzer EO, Ostrom NK, Nelson HS, Bensch GW, Spangler DL, Storms WW, Weinstein SF, Katial RK.

Allergy Asthma Proc. 2014 May-Jun;35 Suppl 1:S20-7. doi: 10.2500/aap.2014.35.3761. Review.

PMID:
25582158
16.

Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.

Nelson HS.

Expert Rev Clin Immunol. 2014 Nov;10(11):1437-51. doi: 10.1586/1744666X.2014.963556. Review.

PMID:
25340426
17.

Update on house dust mite immunotherapy: are more studies needed?

Nelson HS.

Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):542-8. doi: 10.1097/ACI.0000000000000104. Review.

PMID:
25115684
18.

New forms of allergy immunotherapy for rhinitis and asthma.

Nelson HS.

Allergy Asthma Proc. 2014 Jul-Aug;35(4):271-7. doi: 10.2500/aap.2014.35.3778. Review.

PMID:
24992546
19.

Allergen-specific immunotherapy.

Nelson HS, Norman PS.

Chem Immunol Allergy. 2014;100:333-8. doi: 10.1159/000360047.

PMID:
24925414
20.

Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications.

Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA; Childhood Asthma Management Program Research Group..

J Allergy Clin Immunol. 2014 May;133(5):1289-300, 1300.e1-12.

Items per page

Supplemental Content

Loading ...
Support Center